Kopran Research Laboratories Limited

Kopran Research Laboratories Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH1986PLC040601 Incorporated 12 August 1986 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company pharma
Revenue · FY 2025
₹365.89 Cr
▲ 13% YoY
Net profit · FY 2025
₹10.69 Cr
Net margin 2.9%
EBITDA · FY 2025
₹32.7 Cr
EBITDA margin 8.9%
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹22.5 Cr
Issued & subscribed
Open charges
₹194 Cr
Satisfied ₹39.5 Cr
Company age
40 yrs
Est. 1986
Employees · EPFO
609
Provident fund records

About Kopran Research Laboratories Limited

Data last updated:

Kopran Research Laboratories Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Kopran Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 August 1986 and has been in existence for over 40 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1986PLC040601. Its GSTIN is 27AAACK3198E1ZJ (Maharashtra). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹22.5 Cr. It was formerly known as Kopran Formulations Private Limited and Kopran Formulations Limited. It is led by directors including Chandra Mohan Singhi (Whole-Time Director) and Sunita Banerji.

Its last annual general meeting (AGM) was held on 10 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1076 Dr Emmoses Roadparijat House Worli, Mumbai, Maharashtra, India – 400018.

As per the financials filed for FY 2025, the company reported a revenue of ₹365.89 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹10.69 Cr (net margin 2.9%) and EBITDA of ₹32.7 Cr (EBITDA margin 8.9%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 14% over five years.

The company has about 609 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Kopran. As per MCA filings, the company has open charges of ₹194 Cr and satisfied charges of ₹39.5 Cr on record. Court records list 20 cases involving the company, including 7 filed by the company and 13 filed against it; 4 cases are pending. The company has 3 deals on record (1 rights issue, 1 secondary share transfer, 1 acquisition); the latest was in March 2022. Its 4 peer companies in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 3 smaller; the largest is Biochem Pharmaceutical Industries Limited Part IX with revenue of ₹366.61 Cr.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kopran.com.

Company details

CIN U24230MH1986PLC040601
Registration Number 040601
Incorporation Date 12 August 1986
ROC Mumbai
Listing Status Unlisted
Company Status Active
Parent Company Kopran Limited
Compliance Status Active Compliant

Name history

Kopran Research Laboratories has undergone 2 name changes throughout its history. The company was previously known as Kopran Formulations Private Limited, and Kopran Formulations Limited. The current legal name is Kopran Research Laboratories Limited.

Company NameStatus
Kopran Research Laboratories LimitedCurrent
Kopran Formulations Private LimitedPrevious
Kopran Formulations LimitedPrevious

CIN history

Kopran Research Laboratories has one previous CIN (Corporate Identification Number): L24230MH1986PLC040601. The current CIN is U24230MH1986PLC040601, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24230MH1986PLC040601Current
L24230MH1986PLC040601Previous

Contact details

Kopran Research Laboratories Limited's registered office is in Mumbai, Maharashtra. Its website is kopran.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Registered Address
    1076 Dr Emmoses Roadparijat House Worli, Mumbai, Maharashtra, India – 400018
  • Industry
    Pharma, Drug Formulation & Development, API Manufacturers

To see the full contact details of Kopran Research Laboratories Limited, buy the company report.

Comprehensive company report
Kopran Research Laboratories Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Kopran Research Laboratories operates one associated brand: Kopran. Each brand links to its own profile.

BrandDescriptionWebsite
Pharmaceutical Company manufacturing a range of productskopran.com

Business activity

The main business activity of Kopran Research Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Kopran Research Laboratories Limited, buy the company report.

Financials of Kopran Research Laboratories Limited

FY 2024 filings available

Kopran Research Laboratories Limited reported revenue of ₹365.89 Cr (up 13% YoY) for FY 2025.

Revenue · FY 2025
₹365.89 Cr ▲ 13%
Net profit · FY 2025
₹10.69 Cr margin 2.9%
EBITDA · FY 2025
₹32.7 Cr margin 8.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 13%
3 years · compounded
▲ 9%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▼ 20%
3 years · compounded
▼ 24%
5 years · compounded
▲ 9%

Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 13% growth in the latest year. EBITDA fell 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹32.7 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹10.69 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin8.9%
Net Profit Margin2.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Kopran Research Laboratories Limited, buy the company report.

Board of directors of Kopran Research Laboratories Limited

Kopran Research Laboratories has 5 current directors and 15 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sunita BanerjiDirector01 Mar 201610 Years 8 MonthsCurrent
Rakesh Arunkumar DoshiDirector14 Nov 20179 Years 0 MonthsCurrent
Chandra Mohan SinghiWhole-Time Director24 Jun 201511 Years 4 MonthsCurrent
Vandana Surendra SomaniDirector18 Feb 201511 Years 8 MonthsCurrent
Mamta Ashok BiyaniDirector14 Nov 20179 Years 0 MonthsCurrent

Peer comparison

Kopran Research Laboratories Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Biochem Pharmaceutical Industries Limited Part IX₹366.61 Cr (FY 2016)15.0%Ahmedabad, Gujarat, India
Kopran Research Laboratories Limitedthis company₹365.89 Cr (FY 2025)₹10.69 Cr2.9%13.0%609Mumbai, Maharashtra, India
Geltec Private Limited₹362.73 Cr (FY 2025)7.0%Mumbai, Maharashtra, India
Vital Laboratories Private Limited₹357.13 Cr (FY 2025)7.0%Mumbai, Maharashtra, India
Mepro Pharmaceuticals Private Limited₹356.46 Cr (FY 2025)20.0%Surendra Nagar, Gujarat, India

To see the full peer comparison of Kopran Research Laboratories Limited, buy the company report.

Auditor

Kopran Research Laboratories Limited is audited by NGS & Co. LLP for the financial year 2024.

Auditor firmFinancial yearFirm registration number
NGS & Co. LLPFY 2024119850W

Shareholding

The shareholding of Kopran Research Laboratories Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Kopran Research Laboratories Limited, buy the company report.

Charges & borrowings

Open charges
₹194 Cr
Satisfied charges
₹39.5 Cr
Breakdown by lending institutions
Sbicap Trustee Company Limited₹124.75 Cr
State Bank of India₹69.25 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Jul 2020100360412State Bank of India₹69.25 CrOpen
09 May 2016100028872Sbicap Trustee Company Limited₹124.75 CrOpen
04 May 2023100726717Others₹28 CrSatisfied
16 Mar 2021100437722Yes Bank Limited₹11.5 CrSatisfied

To see the full charge records of Kopran Research Laboratories Limited, buy the company report.

Total charge records: 4 View all charges

Deals & funding

Kopran Research Laboratories Limited has 3 deals on record (1 rights issue, 1 secondary share transfer, 1 acquisition); the latest was in March 2022.

Total deals
3
Rights issue
1
Secondary share transfer
1
Acquisition
1

Deals on record (3 of 3)

WhenDealAmountParties
Mar 2022Rights issue₹100 CrInvestors: Kopran Limited
Mar 2015Secondary share transferUndisclosedBuyer: Kopran Lifesciences Limited
Seller: Kopran Limited
Mar 2015Acquisition₹150 CrBuyer: Kopran Limited

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Kopran Research Laboratories Limited was last rated by Crisil on 07 Oct 2020.

Rating agencyRated onRating
Crisil07 Oct 2020

To see the full credit ratings and regulatory alerts of Kopran Research Laboratories Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Kopran Research Laboratories Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Kopran Research Laboratories Limited has a workforce of 609 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
609
Active EPFO establishments
1
Employee growth
-1.1%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27609
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Kopran Research Laboratories Limited, buy the company report.

GST

Kopran Research Laboratories has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
27AAACK3198E1ZJMaharashtraActive01 Jul 2017
24AAACK3198E1ZPGujaratActive01 Jun 2018

To see the full GST registrations and return filing status of Kopran Research Laboratories Limited, buy the company report.

Recent activity

Kopran Research Laboratories Limited has 15 board changes on record since 2011: 5 appointments and 10 cessations. The latest: Rakesh Arunkumar Doshi ceased to be Director on 31 Jul 2019.

Charges
A charge registered on 04 May 2023 via Charge ID 100726717 with Others was fully satisfied on 23 Jun 2025.
Charges
A charge registered on 16 Mar 2021 via Charge ID 100437722 with Yes Bank Limited was fully satisfied on 14 May 2025.
AGM
Kopran Research Laboratories Limited last Annual general meeting of members was held on 10 Sep 2024 as per latest MCA records.
Charges
A charge with State Bank Of India of Rs. 69.25 Cr registered on 30 Jul 2020 with Charge ID 100360412 was modified on 21 May 2024.
Filing
Kopran Research Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Sbicap Trustee Company Limited of Rs. 124.75 Cr registered on 09 May 2016 with Charge ID 100028872 was modified on 28 Mar 2024.
Charges
A charge with Others amounted to Rs. 28.00 Cr with Charge ID 100726717 was registered on 04 May 2023.
Charges
A charge with Yes Bank Limited amounted to Rs. 11.50 Cr with Charge ID 100437722 was registered on 16 Mar 2021.
Charges
A charge with State Bank Of India amounted to Rs. 69.25 Cr with Charge ID 100360412 was registered on 30 Jul 2020.
Ceased
Rakesh Arunkumar Doshi ceased to be Director.
Ceased
Mamta Ashok Biyani ceased to be Additional Director.
Appointed
Mamta Ashok Biyani was appointed as Director.

14 earlier events are in the company report.

Frequently asked questions

Kopran Research Laboratories is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 August 1986 (40+ years old) and is registered under CIN U24230MH1986PLC040601.

Kopran Research Laboratories has 5 current directors:

The latest financial statements of Kopran Research Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 10 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Kopran Research Laboratories is 27AAACK3198E1ZJ, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AAACK3198E1ZP (Gujarat).

The CIN (Corporate Identification Number) of Kopran Research Laboratories is U24230MH1986PLC040601. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Kopran Research Laboratories has 20 court cases on record: 7 filed by the company and 13 filed against it. 4 are pending. Most are in the district courts.

Kopran Research Laboratories was incorporated on 12 August 1986, making it 40+ years old. It is registered with the Registrar of Companies, Mumbai.

Kopran Research Laboratories has 3 deals on record (1 rights issue, 1 secondary share transfer, 1 acquisition); the latest was in March 2022.

The peers of Kopran Research Laboratories by revenue are Biochem Pharmaceutical Industries Limited Part IX, Geltec Private Limited, Vital Laboratories Private Limited, Mepro Pharmaceuticals Private Limited, all in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Rakesh Arunkumar Doshi ceased to be Director on 31 Jul 2019. Mamta Ashok Biyani ceased to be Additional Director on 17 Sep 2018. Mamta Ashok Biyani was appointed as Director on 14 Nov 2017. Kopran Research Laboratories has 15 board changes on record in total.

Kopran Research Laboratories can be reached through the website kopran.com. Its registered office is in Mumbai, Maharashtra, India.